NDC 45802-923-49 - Mesalamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45802-923
- Requested NDC
- 45802-923-49
- Package NDCs from labels
- 45802-923-41, 45802-923-49
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mesalamine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Mesalamine - Padagis Israel Pharmaceuticals Ltd | Padagis Israel Pharmaceuticals Ltd | 2024-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Mesalamine - Perrigo New York Inc | Perrigo New York Inc | 2019-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-098-46 | Mesalamine | 60 mL in 1 BOTTLE | ENEMA | 420 mL | 4 g in 60mL | 14 |
| 45802-923-41 | Mesalamine | 1 in 1 CARTON | KIT | 1 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-923-41 | EA - Each | 45802-923 | ff56bce9-918f-4737-9443-505a0c3cc292 | 1 | 2012-07-24 |
| 45802-923-49 | EA - Each | 45802-923 | 730d663e-9f62-4882-a01f-5031f344fdba | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Ingenus Pharmaceuticals, LLC | 58503afe-b8d4-4710-a194-e3acd64ecf1f | 2025-12-05 | Warnings, Adverse reactions | 4Q81I59GXC |
| Anti Nausea Liquid Cherry Flavor | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 743b215a-81cc-408c-9375-4f427161a05b | 2025-12-04 | Warnings | IY9XDZ35W2 |
| QUALITY CHOICE Anti-Nausea | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 68207fa3-3f69-4405-9191-be702e1bf520 | 2025-12-04 | Warnings | IY9XDZ35W2 |
| Mesalamine | MESALAMINE | Upsher-Smith Laboratories, LLC | 1e6978d0-01db-477d-a90f-27561777480f | 2025-12-01 | Warnings, Adverse reactions | 4Q81I59GXC |
| Walgreen Anti Nausea Cherry Flavor | PHOSPHORATED CARBOHYDRATE | WALGREENS CO. | 69e72d30-feca-454d-addc-8ed7325568d3 | 2025-12-01 | Warnings | IY9XDZ35W2 |
| BUDDATE REGES INTENSIVE TREATMENT | BUTYLENE GLYCOL, HYDROGENATED COCONUT OIL, BUTYROSPERMUM PARKII (SHEA) BUTTER, PALMITOYL TRIPEPTIDE-1, PALMITOYL TETRAPEPTIDE-7 | BUDDATE Co Ltd | 46495321-fb14-3479-e054-00144ff88e88 | 2025-11-30 | Warnings | 3XUS85K0RA |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | 3XUS85K0RA |
| Drainer | CYNARA SCOLYMUS, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, BENZOICUM ACIDUM, BERBERIS VULGARIS, BRYONIA, CANTHARIS, CARDUUS BENEDICTUS, CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CINCHONA OFFICINALIS, DIOSCOREA VILLOSA, DOLICHOS PRURIENS, IRIS VERSICOLOR, JUNIPERUS COMMUNIS, NUX VOMICA, PTELEA TRIFOLIATA, TARAXACUM OFFICINALE, URICUM. | Newton Laboratories, Inc. | 99ff92f5-91bc-120b-e053-2995a90a8d8a | 2025-11-26 | Warnings | 8SKN0B0MIM |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.